[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:megalencephaly-capillary-malformation":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Megalencephaly capillary malformation",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06789913","A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)",[11],"Phase 2","RECRUITING","2026-08-26T02:17:21.315591Z","2026-07-05T05:32:16.695791Z",[],[]]